YKL-40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma.
Anna J JamesBjörn NordlundJon R KonradsenChristina EbersjöSven-Erik DahlénEva Berggren BroströmGunilla HedlinPublished in: Acta paediatrica (Oslo, Norway : 1992) (2020)